GenePath has been providing molecular diagnostic and genomic testing services and products, across infectious diseases, oncology and inherited genetic disorders for the clinical healthcare and research markets in India since 2008, with nearly 200,000 clinical and research samples having been tested at our state of the art NABL approved clinical laboratory located in Pune, India.
Since 2018, the company has also been providing molecular diagnostic and genomic testing products across the world; primarily in Europe, Africa, the Middle East and Southeast Asia. In each of these territories,
GenePath products are sold within the appropriate regulatory framework. In the United States, GenePath offers custom manufactured molecular and genomic reagents for the research use only (RUO) market.
Over a 100 laboratories across the world use GenePath test kits or custom manufactured reagents.
